Skip to content

The effects of synbiotic supplemention on antioxidant capacity in breast cancer-related lymphedema

The effect of symbiotic supplementation on superoxide dismutase and malondialdehyde in breast cancer-related lymphedema

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017092323861N8
Enrollment
88
Registered
2017-11-20
Start date
2017-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphedema. Breast, unspecified

Interventions

Treatment - Drugs
Placebo
Intervention group: Weight loss diet consultation (At the beginning of the study all the participants, according to their age, height, weight and calculating Energy Expenditure, should follow the weig
Control group: weight loss diet consultation (At the beginning of the study all the participants, according to their age, height, weight and calculating Energy Expenditure, should follow the weight lo

Sponsors

Vice Chancellor for Research, Iran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: women with unilateral breast cancer related lymphedema; breast cancer lymphedema in stage 2; Age range 18-60, BMI = 25 - 35 Kg.m2; At least one month has passed since the last treatment such as radiotherapy; Willingness to participate in the study and sign a written informed consent. Exclusion criteria: Use of multivitamin minerals and omega 3 supplements up to 1 month before the study began; Inflammatory diseases such as heart failure, pulmonary, kidney and diabetes; autoimmune diseases such as rheumatoid arthritis; Acute and chronic infection; taking Probiotics supplementation from 6 months before study; having a weight loss diet in Length 6 months before the study ; Smoking and Alcohol consumption; Lymphedema due to other cancers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Superoxide Dismutase, Malondialdehyde. Timepoint: before and after intervantion. Method of measurement: Colorimetric, Colorimetric/ Fluorometric.

Secondary

MeasureTime frame
Total Antioxidant Capacity. Timepoint: before and after intervantion. Method of measurement: Colorimetric.;Glutathione Peroxidase. Timepoint: before and after intervantion. Method of measurement: Colorimetric.;Volume of lymphedema. Timepoint: before and after intervantion. Method of measurement: tank water.;BMI. Timepoint: before and after intervantion. Method of measurement: formula.;Waist circumference. Timepoint: before and after intervantion. Method of measurement: meter.;Waist to hip ratio. Timepoint: before and after intervantion. Method of measurement: formula.;Skinfold thickness. Timepoint: before and after intervantion. Method of measurement: caliper.;Nutritional status. Timepoint: before and after intervantion. Method of measurement: Measurement of energy and nutrients intake using 24-hour dietary recall method and anthropometric measurement using scale and stadiometer.;Physical Activity. Timepoint: before and after intervantion. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMitra Zarrati

Iran University of Medical Sciences, School of Public Health

zarrati.m@iums.ac.ir+98 21 8670 4814

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026